Cargando…
Growth factors in ischemic stroke
Data from pre-clinical and clinical studies provide evidence that colony-stimulating factors (CSFs) and other growth factors (GFs) can improve stroke outcome by reducing stroke damage through their anti-apoptotic and anti-inflammatory effects, and by promoting angiogenesis and neurogenesis. This rev...
Autores principales: | Lanfranconi, S, Locatelli, F, Corti, S, Candelise, L, Comi, G P, Baron, P L, Strazzer, S, Bresolin, N, Bersano, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373358/ https://www.ncbi.nlm.nih.gov/pubmed/20015202 http://dx.doi.org/10.1111/j.1582-4934.2009.00987.x |
Ejemplares similares
-
Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
por: Lanfranconi, S., et al.
Publicado: (2011) -
POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome
por: Cheldi, Antonella, et al.
Publicado: (2013) -
A novel CCM1 mutation associated with multiple cerebral and vertebral cavernous malformations
por: Lanfranconi, Silvia, et al.
Publicado: (2014) -
Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke
por: Zangari, R., et al.
Publicado: (2016) -
MicroRNAs as regulators of cell death mechanisms in amyotrophic lateral sclerosis
por: Gagliardi, Delia, et al.
Publicado: (2019)